Statistical flags indicate unusual patterns — not proof of fraud or wrongdoing. Read our methodology

MARY M. GOOLEY HEMOPHILIA CENTER INC

Clinic/Center·ROCHESTER, NY·NPI: 1568428621Share

Compared to Clinic/Center Peers

Total spending distribution among 13 providers in this specialty

P25MedianP75P90

This provider's total spending of $22.9M is at the 50th percentile among 13 Clinic/Center providers.

Active Billing Period:2020-062024-11(47 months)

Extreme procedure concentration — 100% of $22.9M billed through just 2 codes

Total Paid

$22.9M

$22,884,793

Total Claims

1,379

Beneficiaries

777

1.8 claims/patient

Avg Cost/Claim

$17K

Monthly Spending Trend

Yearly Spending

2020
$361K
+1539%
2021
$5.9M
+23%
2022
$7.3M
-16%
2023
$6.1M
-47%
2024
$3.3M

Procedure Breakdown

Cost per claim compared to national benchmarks

This provider bills for 2 distinct procedure codes. The top code (J7170 (Emicizumab-kxwh (Hemlibra) injection, 0.5 mg)) accounts for 100% of total spending.

J7170Normal range

Emicizumab-kxwh (Hemlibra) injection, 0.5 mg

$22.9M

977 claims · 100.0%

Your Cost: $23,418.64/claim|Median: $23,418.64
1.0× median
S9345Normal range

$5K

402 claims · 0.0%

Your Cost: $11.90/claim|Median: $41.98
0.3× median